As the rumors surrounding Apple's mythical iWatch continue to swell, Apple has continued to hire folks with deep biomedical and sensor technology expertise.
A previously unreported addition to Apple's growing cadre of medical device experts is Marcelo Malini Lamego, who began working at Apple this January.
Before joining Apple this past January, Lamego spent 8 years as the CTO of Cercacor, a medical devices company with a focus on developing noninvasive monitoring technologies.
As CTO, Lamego spearheaded the company's engineering and R&D efforts, where he helped develop the Pronto-7, an award-winning and noninvasive medical device capable of measuring a patient's oxygen saturation and hemoglobin levels, along with a patient's pulse rate. The Pronto-7 is currently being sold by Masimo, a company specializing in noninvasive patient monitoring technologies.
Lamego's LinkedIn profile reads in part:
Click on the image to enlarge.
Lamego further writes in his LinkedIn profile that he's an inventor on "more than 70 patent applications/patents related to optimization and signal processing, devices, sensors and patient monitoring technologies..."
Prior to working at Cercacor, Lamego worked for nearly four years as a Research Scientist at Masimo. While there, he was the lead scientist involved in the development of the Rainbow Technology platform, which Masimo describes as follows:
Masimo rainbow is a noninvasive monitoring platform enabling the assessment of multiple blood constituents and physiologic parameters that previously required invasive or complicated procedures.
The underlying technologies of the Rainbow Technology platform are rather impressive:
- Innovative noninvasive sensor technology uses more than 7 wavelengths of light to acquire blood constituent data based on light absorption
- Advanced signal processing algorithms and unique adaptive filters work together to isolate, identify and quantify various hemoglobin species
Another example of a Masimo product which utilizes the Rainbow Technology platform comes in the form of a neck patch that continuously measures a patient's respiration rate and works to alert physicians "to the first sign of an abnormal or compromised breathing pattern."
And just what will Lamego be working on at Apple?
All we know at this point is that he's involved in R&D, but given his past work and fields of expertise, it stands to reason that he's working on sensor technologies in some sort of capacity. Just how involved he is with Apple's rumored iWatch project remains open to speculation.
You might recall that Apple last summer reportedly hired Michael O'Reilly, the former Chief Medical Officer and Executive VP for Medical Affairs at Masimo. 9to5Mac reported a few weeks ago that O'Reilly's work at Apple does not "solely focus on the iWatch project."
Sign up for Computerworld eNewsletters.